Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Raw Materials (2023 - 2025)

Historic Raw Materials for Solventum (SOLV) over the last 3 years, with Q3 2025 value amounting to $233.0 million.

  • Solventum's Raw Materials fell 411.52% to $233.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.0 million, marking a year-over-year decrease of 411.52%. This contributed to the annual value of $236.0 million for FY2024, which is 128.76% up from last year.
  • As of Q3 2025, Solventum's Raw Materials stood at $233.0 million, which was down 411.52% from $236.0 million recorded in Q2 2025.
  • Over the past 5 years, Solventum's Raw Materials peaked at $243.0 million during Q3 2024, and registered a low of $211.0 million during Q1 2025.
  • Moreover, its 3-year median value for Raw Materials was $234.5 million (2023), whereas its average is $232.5 million.
  • Within the past 5 years, the most significant YoY rise in Solventum's Raw Materials was 350.88% (2025), while the steepest drop was 1208.33% (2025).
  • Quarter analysis of 3 years shows Solventum's Raw Materials stood at $233.0 million in 2023, then increased by 1.29% to $236.0 million in 2024, then decreased by 1.27% to $233.0 million in 2025.
  • Its Raw Materials stands at $233.0 million for Q3 2025, versus $236.0 million for Q2 2025 and $211.0 million for Q1 2025.